DRβ1*04:01第71位谷氨酸替换与胶原特异性耐受且不诱导同种异体反应
研究将DRβ1*04:01第71位赖氨酸替换为谷氨酸,构建DRB1*04:01K71E等位基因,在T2细胞系检测肽结合、在转基因小鼠检测胶原致敏与T细胞增殖,并进行皮肤和骨髓移植。结果显示该替换阻断胶原肽结合、使小鼠抵抗胶原致敏,且DRB1*04:01小鼠不排斥DRB1*04:01K71E的皮肤和骨髓移植物,骨髓可过继转移胶原特异性耐受。
要点
- DRβ1*04:01第71位赖氨酸替换为谷氨酸可阻断胶原肽结合。
- DRB1*04:01K71E小鼠对胶原致敏产生抵抗。
- DRB1*04:01小鼠不排斥DRB1*04:01K71E的皮肤和骨髓移植物。
核心结论
- 编辑DRβ1*04:01单个氨基酸可阻断胶原肽结合且不诱导同种异体反应,可能代表一种诱导抗原特异性被动耐受的基因治疗方法。
研究设计与样本
- 将各DRB1等位基因及DRB1*04:01K71E等位基因克隆入T2细胞系以检测生物素化肽结合。
- 使用表达DRB1*04:01、DRB1*01:01或DRB1*04:01K71E的转基因动物注射胶原以检测T细胞增殖。
- 在DRB1*04:01K71E与DRB1*04:01小鼠间进行皮肤和骨髓移植以判断第71位单氨基酸改变是否被识别为异物。
- 对移植DRB1*04:01K71E骨髓的DRB1*04:01小鼠注射胶原以检测胶原致敏抵抗能否被转移。
主要发现
- 将DRβ1*04:01第71位赖氨酸(K)替换为谷氨酸(E)可阻断胶原肽结合,并使DRB1*04:01K71E小鼠对胶原致敏产生抵抗。
- DRB1*04:01小鼠未排斥来自DRB1*04:01K71E小鼠的皮肤和骨髓移植物,提示单一E71差异未被识别为同种异体。
- 来自DRB1*04:01K71E小鼠的骨髓可将针对胶原的抗原特异性耐受过继转移给DRB1*04:01小鼠。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The DRB1 locus is strongly associated with both susceptibility and resistance to rheumatoid arthritis (RA). DRB1 alleles encoding the VKA or VRA epitope in positions 11, 71, and 74 confer the highest risk of developing RA, whereas the allele encoding VEA is protective. We therefore investigated the feasibility of creating antigen-specific tolerance without inducing alloreactivity by replacing lysine with glutamic acid at position 71 in DRβ1*04:01. METHODS: Individual DRB1 alleles and the DRB1*04:01K71E allele were cloned into T2 cell lines to measure binding of biotinylated peptides. Transgenic animals expressing DRB1*04:01, DRB1*01:01, or DRB1*04:01K71E were injected with collagen to measure T cell proliferation. Skin and bone marrow transplants between DRB1*04:01K71E and DRB1*04:01 mice were performed to determine if the single amino acid change at position 71 would be recognized as foreign. DRB1*04:01 mice transplanted with DRB1*04:01K71E bone marrow were injected with collagen to test if resistance to collagen sensitization could be transferred. RESULTS: Replacing lysine (K) at position 71 in DRβ1*04:01 with glutamic acid (E) blocked collagen peptide binding and rendered the DRB1*04:01K71E mice resistant to collagen sensitization. Skin and bone marrow transplants from DRB1*04:01K71E mice were not rejected by DRB1*04:01 mice, suggesting the single E71 difference was not recognized as allogeneic. Bone marrow from DRB1*04:01K71E mice adoptively transferred antigen-specific tolerance to collagen to DRB1*04:01 mice. CONCLUSION: These studies demonstrate that editing a single amino acid in DRβ1*04:01 blocks collagen peptide binding without inducing alloreactivity and could therefore represent a gene therapy approach to induce antigen-specific passive tolerance.
引用
- Jha V, Freed BM, Sunderhaus ER, et al. Substitution of Glutamic Acid at Position 71 of DRβ1*04:01 and Collagen-Specific Tolerance Without Alloreactivity. Arthritis Rheumatol. 2025. PMID: 39609038. doi:10.1002/art.43067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。